CorMedix develops and sells DefenCath, a catheter lock solution for dialysis patients, plus hospital infection drugs and a heart medicine. It last closed at $5.27 on Nov 20, up 3.74% on the day. The next earnings report for CRMD is expected around Thu, Mar 4, 2027. For the quarter ended Sep 2026, CRMD reported EPS of -$0.19 on revenue of $54.5M, with revenue down 47.7% from a year ago. Over its last 8 reports the stock moved an average of 15.3% the session after earnings. Over the last 12 months CRMD insiders bought $588K of stock on the open market and sold $2.3M, according to SEC Form 4 filings.
AI Auto Pilots
Is CRMD in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold CRMD.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on CRMDStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
CRMD · as of the Nov 20 close · updated each morning
Downtrend
The stock is 9% below its 20 day and 30% below its 50 day average. It is 42% below its 200 day average, so the longer trend is down. Momentum is neutral (RSI 40). The nearest support is the Pivot at $5.18, and the nearest resistance the Pivot R1 at $5.41.
Short trendBearish
Long trendBearish
MomentumNeutral
StretchNormal
VolatilityHigh, 7.9%/day
Key levels
$13.0252 week high+147.1%
$7.66Swing high (Aug 4)+45.4%
$7.49200 day average+42.1%
$7.46100 day average+41.6%
$6.8650 day average+30.2%
$5.7320 day average+8.7%
$5.41Pivot R1+2.7%
$5.27Last close
$5.18Pivot−1.7%
$5.10Swing low (Nov 6)−3.2%
$5.04Pivot S1−4.4%
$4.4652 week low−15.4%
Indicators
RSI (14)
40.39
Middle of its range
Neutral
MACD
-0.65
Above its signal line
Bullish
Stochastic
35.9
Middle of its range
Neutral
ADX (14)
34.4
Trending down
Williams %R
-39.3
Oversold below −80, overbought above −20
Neutral
CCI (20)
-44.1
Oversold below −100, overbought above 100
Neutral
Rate of change
−0.9%
Change over 10 sessions
Bearish
ATR (14)
$0.42
Typical daily range, 7.9% of price
MA 10Above
MA 20Below
MA 50Below
MA 100Below
MA 200Below
Turning down, nearing oversold
Short trendBearish
Long trendNeutral
MomentumWeak
StretchNear oversold
VolatilityNormal, 17.0%/day
Key levels
$13.0252 week high+147.1%
$7.66Swing high (Aug 4)+45.4%
$7.49200 day average+42.1%
$7.46100 day average+41.6%
$6.8650 day average+30.2%
$5.7320 day average+8.7%
$5.41Pivot R1+2.7%
$5.27Last close
$5.18Pivot−1.7%
$5.10Swing low (Nov 6)−3.2%
$5.04Pivot S1−4.4%
$4.4652 week low−15.4%
Indicators
RSI (14)
34.86
Weak, oversold below 30
Neutral
MACD
-0.71
Below its signal line
Bearish
Stochastic
8.2
Near the bottom of its range
Oversold
ADX (14)
15.2
No clear trend
Williams %R
-81.2
Oversold below −80, overbought above −20
Oversold
CCI (20)
-204.1
Oversold below −100, overbought above 100
Oversold
Rate of change
−32.6%
Change over 10 sessions
Bearish
ATR (14)
$0.90
Typical daily range, 17.0% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for CRMD
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how CRMD did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
November seasonalityHow CRMD usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for CRMDHow many large options trades hit CRMD, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in CRMD in the last 90 days.
From SEC Form 4 filings by CRMD's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether CRMD is in one of them and how their past CRMD trades turned out.
CorMedix is a biopharmaceutical company based in Parsippany, New Jersey, that develops and sells drugs for serious medical conditions. Its main product is DefenCath, a catheter lock solution that helps reduce bloodstream infections in adult kidney failure patients who receive dialysis through a central venous catheter. Its customers are mainly outpatient dialysis clinics and hospitals. The company also sells a set of hospital-focused drugs for serious infections, including REZZAYO and VABOMERE, along with the heart drug TOPROL XL. These products are used in hospitals, emergency departments, outpatient clinics and home infusion care.